QuidelOrtho (QDEL) Net Cash Flow Growth (3y) (2024 - 2026)

QuidelOrtho (QDEL) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.48 Bn 176.19 Bn 6.27 Bn -32.51%
2 Stryker 129.11 Bn 126.23 Bn 3.81 Bn -87.87%
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn 31.32%
4 Boston Scientific 68.68 Bn 67.22 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn -87.88%
6 Dexcom 28.38 Bn 27.26 Bn 750.30 Mn 129.29%
7 GE HealthCare Technologies 28.04 Bn 25.76 Bn 1.98 Bn -65.12%
8 Smith & Nephew 26.92 Bn 26.35 Bn - -
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn -48.90%
10 QuidelOrtho 1.15 Bn 1.01 Bn - -35.48%

Historic Data

Download Data
DateValue
Mar 29, 2026 -35.48%
Dec 28, 2025 28.45%
Mar 30, 2025 -61.49%
Sep 29, 2024 64.33%